BRIEF published on 09/05/2025 at 14:35, 6 months 13 days ago Wellgistics Health to Present at Key September Investor Conferences Investor Conferences AI-driven Solutions Pharmaceutical Distribution Wellgistics Health Brian Norton
PRESS RELEASE published on 09/05/2025 at 14:30, 6 months 13 days ago Wellgistics Health, Inc. to Present at September Investor Conferences Wellgistics Health to present at three investor conferences in September 2025 to showcase strategic vision and innovations. CEO Brian Norton emphasizes importance of visibility and engagement Investor Conferences Future Growth Pharmaceutical Distribution Wellgistics Health AI-powered Hub Fulfillment
BRIEF published on 08/27/2025 at 14:05, 6 months 22 days ago Wellgistics Health Launches HubRx AI to Revolutionize Prescription Services Healthcare Automation Wellgistics Health HubRx AI AI-powered Prescription Pharma Market
PRESS RELEASE published on 08/27/2025 at 14:00, 6 months 22 days ago Wellgistics Health Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem Wellgistics Health introduces HubRx AI, a customizable AI engine for prescription hub services, aiming to streamline operations and enhance patient outcomes Patient Outcomes Wellgistics Health HubRx AI AI Engine Prescription Hub Services
BRIEF published on 08/20/2025 at 15:05, 6 months 29 days ago Wellgistics Health Reports Stability and Growth Initiatives in Mid-2025 Financial Results Growth Initiatives Wellgistics Health Operational Integration Direct-to-Patient
PRESS RELEASE published on 08/20/2025 at 15:00, 6 months 29 days ago Wellgistics Health Achieves Stability in First-Half 2025 and Executes Growth Initiatives Wellgistics Health, Inc. announces financial results for the second fiscal quarter ending June 30, 2025. Transformational progress and strategic initiatives highlighted Financial Results Strategic Initiatives Wellgistics Health Direct-to-Patient Transformational Progress
BRIEF published on 08/14/2025 at 14:35, 7 months 4 days ago Wellgistics Health Ends Equity Line of Credit to Focus on Growth Growth Strategy AI Technology Pharmaceutical Distribution Wellgistics Health Equity Line Termination
PRESS RELEASE published on 08/14/2025 at 14:30, 7 months 4 days ago Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy Wellgistics Health terminates equity purchase agreement with Hudson Global Ventures, LLC to focus on long-term shareholder value. Strategic shift towards accretive financing and growth opportunities Shareholder Value Termination Equity Purchase Agreement Wellgistics Health Accretive Financing
BRIEF published on 07/25/2025 at 13:50, 7 months 24 days ago Wellgistics Health Converts $8.1M Debt to Equity Shareholder Value AI Technology Pharmaceutical Distribution Debt-to-equity U.S. Healthcare
PRESS RELEASE published on 07/25/2025 at 13:45, 7 months 24 days ago Wellgistics Health Converts $8.1M Debt to Equity Wellgistics Health approves $8.1 million debt-to-equity conversion to enhance financial position and accelerate growth, aiming to transform the prescription drug marketplace Financial Growth Pharmaceutical Distribution Debt-to-equity Conversion Wellgistics Health AI-powered Hub Fulfillment
Published on 03/19/2026 at 13:30, 12 minutes ago Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 12 minutes ago ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results
Published on 03/19/2026 at 13:15, 27 minutes ago Worksport Presents New Premium "Game Changer" Tonneau Cover Model to Industry Buyers at Keystone BIG Show; Initiates Pre-Orders Ahead of Near-Term Commercial Launch
Published on 03/19/2026 at 13:10, 32 minutes ago Adcore to Publish Fourth Quarter and 2025 Year End Results on March 26th, 2026
Published on 03/19/2026 at 13:00, 42 minutes ago Dateline Secures Second Rig to Fast-Track Colosseum REE Program
Published on 03/19/2026 at 13:10, 32 minutes ago DCK Showcases Expanded Professional Power Tool and Outdoor Power Equipment Portfolio at EISENWARENMESSE 2026, Strengthening European Market Commitment
Published on 03/19/2026 at 13:00, 42 minutes ago Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard
Published on 03/19/2026 at 12:56, 46 minutes ago ABB Ltd: ABB shareholders approve all proposals at 2026 annual general meeting
Published on 03/19/2026 at 12:10, 1 hour 32 minutes ago ZPMC Completes First Emissions Rights Transaction in Shanghai
Published on 03/19/2026 at 08:45, 4 hours 57 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 6 hours 42 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 6 hours 42 minutes ago 2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 18 hours 1 minute ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 19 hours 42 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
